CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Aili L LazaarBruce E MillerAlison C DonaldThomas KeeleyClaire AmberyJohn RussellHenrik WatzRuth Tal-Singernull nullPublished in: Respiratory research (2020)
This study was registered with clinicaltrials.gov, NCT03034967.
Keyphrases